Loading...
Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
The discovery of new drugs for treating the new coronavirus (SARS-CoV-2) or repurposing those already in use for other viral infections is possible through understanding of the viral replication cycle and pathogenicity. This article highlights the advantage of targeting one of the non-structural pro...
Na minha lista:
| Udgivet i: | Arch Med Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
IMSS. Published by Elsevier Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261434/ https://ncbi.nlm.nih.gov/pubmed/32536457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.arcmed.2020.05.024 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|